Intracytoplasmic staining for fibromodulin and surface-membrane staining for CD5 and CD19 of leukemic cells. (A) Patient with B-CLL and (B) PBMCs from a healthy control donor (1 representative experiment). The shaded curve represents background staining with a control antibody (see “Patients, materials, and methods”). Figures in brackets indicate percentages of positive cells.